RXi Pharmaceuticals to Present at the 13th Annual Rodman & Renshaw Healthcare Conference
September 08 2011 - 7:10AM
RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology
company focused on discovering, developing and commercializing
innovative therapies addressing major unmet medical needs using
targeted biotherapeutics, today announced that Mark J. Ahn,
President and CEO, will present a corporate overview at the 13th
Annual Rodman & Renshaw Healthcare conference. The presentation
will take place on Monday, September 12, 2011 at 4:30 pm EDT at the
Waldorf Astoria Hotel in New York, NY.
The presentation will be webcast and available on the Investors
section of the Company's website at www.rxipharma.com.
About RXi Pharmaceuticals Corporation
RXi Pharmaceuticals Corporation (Nasdaq:RXII) is a biotechnology
company focused on discovering, developing and commercializing
innovative therapies addressing major unmet medical needs using
targeted biotherapeutics. For more information, visit
www.rxipharma.com.
The RXi Pharmaceuticals Corporation logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10128
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements include, but are not limited to, statements
about the future expectations, plans and prospects of the
development of RXi Pharmaceuticals Corporation's products. These
forward-looking statements about future expectations, plans and
prospects of the development of the Company's products are subject
to a number of risks, uncertainties and assumptions, including
those identified under "Risk Factors" in the Company's most
recently filed Annual Report on Form 10-K, Quarterly Report on Form
10-Q and in other filings the Company periodically makes with the
SEC. Actual results may differ materially from those contemplated
by these forward-looking statements. The Company does not undertake
to update any of these forward-looking statements to reflect a
change in its views or events or circumstances that occur after the
date of this presentation.
CONTACT: RXi Pharmaceuticals
Tamara McGrillen
508-929-3615
ir@rxipharma.com
or
Remy Bernarda
IR Sense, LLC
415-203-6386
remy@irsense.com
RXI Pharmaceuticals Corporation (NASDAQ:RXII)
Historical Stock Chart
From Aug 2024 to Sep 2024
RXI Pharmaceuticals Corporation (NASDAQ:RXII)
Historical Stock Chart
From Sep 2023 to Sep 2024